AGP Executive Report
Last update: 7 hours agoUK Medical Access: Boots is launching Sure Leaf, the first medical cannabis prescription service from a UK high-street pharmacy. People aged 25 and over with chronic pain, anxiety or insomnia can apply after conventional treatments have failed; clinicians will assess applicants online and by video. Hemp Deadline: Kentucky’s CBD-focused growers and processors warn that a federal rule taking effect Dec. 11 could outlaw many hemp-derived products with more than trace THC unless Congress intervenes. The change could affect more than 100 licensed growers in the state. CBD Insomnia Trial: Australia’s Avecho Biotechnology has resumed recruitment for the final cohort of its late-stage trial of a CBD capsule for insomnia. An interim review backed continuing without expanding the study; a successful result could support an application to register an over-the-counter CBD product.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.